165 related articles for article (PubMed ID: 30538549)
1. High EIF2B5 mRNA expression and its prognostic significance in liver cancer: a study based on the TCGA and GEO database.
Jiao Y; Fu Z; Li Y; Meng L; Liu Y
Cancer Manag Res; 2018; 10():6003-6014. PubMed ID: 30538549
[TBL] [Abstract][Full Text] [Related]
2. Low EIF2B5 expression predicts poor prognosis in ovarian cancer.
Hou L; Jiao Y; Li Y; Luo Z; Zhang X; Pan G; Zhao Y; Yang Z; He M
Medicine (Baltimore); 2020 Jan; 99(5):e18666. PubMed ID: 32000373
[TBL] [Abstract][Full Text] [Related]
3. Expression of eukaryotic translation initiation factor 3 subunit B in liver cancer and its prognostic significance.
Yue Q; Meng L; Jia B; Han W
Exp Ther Med; 2020 Jul; 20(1):436-446. PubMed ID: 32537008
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of SKA3 correlates with poor prognosis in female early breast cancer.
Zhong Y; Zhuang Z; Mo P; Lin M; Gong J; Huang J; Mo H; Lu Y; Huang M
PeerJ; 2021; 9():e12506. PubMed ID: 34993016
[TBL] [Abstract][Full Text] [Related]
5. High Expression of Heat Shock Protein Family D Member 1 Predicts Poor Prognosis of Esophageal Cancer.
Lv J; Wang XW; Sun XK; Yang JR; Chen PR
J Clin Med Res; 2022 Jul; 14(7):273-281. PubMed ID: 35974809
[TBL] [Abstract][Full Text] [Related]
6. Increased E2F2 predicts poor prognosis in patients with HCC based on TCGA data.
Zeng Z; Cao Z; Tang Y
BMC Cancer; 2020 Oct; 20(1):1037. PubMed ID: 33115417
[TBL] [Abstract][Full Text] [Related]
7. HN1 as a diagnostic and prognostic biomarker for liver cancer.
Liu Z; Yang D; Li Y; Jiao Y; Lv G
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32700728
[TBL] [Abstract][Full Text] [Related]
8. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis.
Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F
World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424
[TBL] [Abstract][Full Text] [Related]
9. Aberrant FAM64A mRNA expression is an independent predictor of poor survival in pancreatic cancer.
Jiao Y; Fu Z; Li Y; Zhang W; Liu Y
PLoS One; 2019; 14(1):e0211291. PubMed ID: 30695070
[TBL] [Abstract][Full Text] [Related]
10. Decreased Expression of NUSAP1 Predicts Poor Overall Survival in Cervical Cancer.
Xie Q; Ou-Yang W; Zhang M; Wang H; Yue Q
J Cancer; 2020; 11(10):2852-2863. PubMed ID: 32226503
[No Abstract] [Full Text] [Related]
11. High miR-454-3p expression predicts poor prognosis in hepatocellular carcinoma.
Li Y; Jiao Y; Fu Z; Luo Z; Su J; Li Y
Cancer Manag Res; 2019; 11():2795-2802. PubMed ID: 31114333
[No Abstract] [Full Text] [Related]
12. High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma.
Zhang Q; Xia T; Qi C; Du J; Ye C
BMC Cancer; 2022 Jan; 22(1):77. PubMed ID: 35042454
[TBL] [Abstract][Full Text] [Related]
13. The significance of m6A RNA methylation regulators in predicting the prognosis and clinical course of HBV-related hepatocellular carcinoma.
Fang Q; Chen H
Mol Med; 2020 Jun; 26(1):60. PubMed ID: 32552682
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of MAL2 Correlates with Immune Infiltration and Poor Prognosis in Breast Cancer.
Zhong Y; Zhuang Z; Mo P; Shang Q; Lin M; Gong J; Huang J; Mo H; Huang M
Evid Based Complement Alternat Med; 2021; 2021():5557873. PubMed ID: 34567213
[TBL] [Abstract][Full Text] [Related]
15. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S
BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009
[TBL] [Abstract][Full Text] [Related]
16. PES1 In Liver Cancer: A Prognostic Biomarker With Tumorigenic Roles.
Fu Z; Jiao Y; Li YQ; Ke JJ; Xu YH; Jia BX; Liu B
Cancer Manag Res; 2019; 11():9641-9653. PubMed ID: 31814761
[TBL] [Abstract][Full Text] [Related]
17. CDCA8 as an independent predictor for a poor prognosis in liver cancer.
Shuai Y; Fan E; Zhong Q; Chen Q; Feng G; Gou X; Zhang G
Cancer Cell Int; 2021 Mar; 21(1):159. PubMed ID: 33685433
[TBL] [Abstract][Full Text] [Related]
18. GPSM2 Serves as an Independent Prognostic Biomarker for Liver Cancer Survival.
Yang D; Ji F; Li Y; Jiao Y; Fang X
Technol Cancer Res Treat; 2020; 19():1533033820945817. PubMed ID: 32812493
[TBL] [Abstract][Full Text] [Related]
19. Correlation of zinc finger protein 2, a prognostic biomarker, with immune infiltrates in liver cancer.
Sun L; Lin Y; Wang G; Zhang L; Hu L; Lu Z
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33439969
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and prognostic value of MEX3A mRNA in liver cancer.
Yang D; Jiao Y; Li Y; Fang X
PeerJ; 2020; 8():e8252. PubMed ID: 31998552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
